Stroke Rehabilitation Market Size, Share & Industry Analysis By Product Type (Rehabilitation Equipment [Neurostimulation & Neuromodulation Systems, Cognitive, Speech & Upper-Limb & Hand Rehabilitation Systems] and Assistive Devices [Mobility & Orthotic Devices]), By Therapy Type (Physical Therapy, Occupational Therapy, Cognitive & Behavioral Therapy), By Stroke Type (Ischemic Stroke, Hemorrhagic Stroke, & Transient Ischemic Attack-related Rehabilitation), By Age Group (Adults & Pediatrics), By End User (Hospitals, Rehabilitation Centers, Homecare Settings), and Regional Forecast, 2026-2034

Last Updated: July 17, 2026 | Format: PDF | Report ID: FBI118267

Buy Now

To get information on various segments, share your queries with us

ATTRIBUTE	DETAILS
Study Period	2021-2034
Base Year	2025
Estimated Year	2026
Forecast Period	2026-2034
Historical Period	2021-2024
Growth Rate	CAGR of 9.5% from 2026 to 2034
Unit	Value (USD Million)
Segmentation	By Product Type, Therapy Type, Stroke Type, Age Group, End User, and Region
By Product Type	Rehabilitation Equipment Neurostimulation & Neuromodulation Systems Upper-limb & Hand Rehabilitation Systems Others Assistive Devices Mobility Devices Orthotic Devices Others
By Therapy Type	Physical Therapy Occupational Therapy Cognitive & Behavioral Therapy Others
By Stroke Type	Ischemic Stroke Hemorrhagic Stroke Transient Ischemic Attack-related Rehabilitation
By Age Group	Adults Pediatrics
By End User	Hospitals Rehabilitation Centers Homecare Settings Others
By Region	North America (By Product Type, By Therapy Type, By Stroke Type, By Age Group, By End User, and by Country) U.S. (By Age Group) Canada (By Age Group) Europe (By Product Type, By Therapy Type, By Stroke Type, By Age Group, By End User, and by Country/Sub-region) U.K. (By Age Group) Germany (By Age Group) France (By Age Group) Italy (By Age Group) Spain (By Age Group) Scandinavia (By Age Group) Rest of Europe (By Age Group) Asia Pacific (By Product Type, By Therapy Type, By Stroke Type, By Age Group, By End User, and by Country/Sub-region) China (By Age Group) Japan (By Age Group) India (By Age Group) Australia (By Age Group) Southeast Asia (By Age Group) Rest of Asia Pacific (By Age Group) Latin America (By Product Type, By Therapy Type, By Stroke Type, By Age Group, By End User, and by Country/Sub-region) Brazil (By Age Group) Mexico (By Age Group) Rest of Latin America (By Age Group) Middle East & Africa (By Product Type, By Therapy Type, By Stroke Type, By Age Group, By End User, and by Country/Sub-region) GCC (By Age Group) South Africa (By Age Group) Rest of the Middle East & Africa (By Age Group)